Siegfried Haas

15.1k total citations
17 papers, 68 citations indexed

About

Siegfried Haas is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Siegfried Haas has authored 17 papers receiving a total of 68 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Siegfried Haas's work include Lung Cancer Treatments and Mutations (8 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Siegfried Haas is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Siegfried Haas collaborates with scholars based in Germany, United States and Switzerland. Siegfried Haas's co-authors include Judith Atz, Wolfgang Gleiber, R. Kaiser, Christian Grohé, Stefan Krüger, Christoph Losem, Christian Franke, Nadežda Basara, Werner J. Blau and Ullrich Graeven and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and International Journal of Cancer.

In The Last Decade

Siegfried Haas

17 papers receiving 68 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Siegfried Haas Germany 5 52 42 9 6 6 17 68
Yiu-Keung Lau United States 4 29 0.6× 20 0.5× 9 1.0× 6 1.0× 5 0.8× 10 53
Federica D’Incà Italy 3 31 0.6× 33 0.8× 13 1.4× 9 1.5× 6 1.0× 5 46
Elia Seguí Spain 5 38 0.7× 21 0.5× 22 2.4× 3 0.5× 5 0.8× 19 61
B. Bermejo De Las Heras Spain 5 53 1.0× 33 0.8× 17 1.9× 5 0.8× 2 0.3× 19 68
M.R. García-Campelo Spain 5 77 1.5× 62 1.5× 6 0.7× 21 3.5× 7 1.2× 17 95
Sabela Recalde Spain 5 41 0.8× 22 0.5× 12 1.3× 9 1.5× 5 0.8× 14 58
Daphné t’Kint de Roodenbeke Belgium 4 43 0.8× 20 0.5× 15 1.7× 18 3.0× 6 1.0× 7 60
E. Millastre Spain 2 20 0.4× 34 0.8× 10 1.1× 6 1.0× 3 0.5× 5 47
Sonia Del Barco Berrón Spain 5 36 0.7× 30 0.7× 16 1.8× 11 1.8× 3 0.5× 13 62
Annette Kolodzie United States 4 35 0.7× 20 0.5× 22 2.4× 17 2.8× 4 0.7× 6 58

Countries citing papers authored by Siegfried Haas

Since Specialization
Citations

This map shows the geographic impact of Siegfried Haas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siegfried Haas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siegfried Haas more than expected).

Fields of papers citing papers by Siegfried Haas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siegfried Haas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siegfried Haas. The network helps show where Siegfried Haas may publish in the future.

Co-authorship network of co-authors of Siegfried Haas

This figure shows the co-authorship network connecting the top 25 collaborators of Siegfried Haas. A scholar is included among the top collaborators of Siegfried Haas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siegfried Haas. Siegfried Haas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Modest, Dominik Paul, Ullrich Graeven, Lothar Müller, et al.. (2024). FU/FA maintenance therapy with or without panitumumab (pmab) in RAS wild-type metastatic colorectal cancer (mCRC) (PanaMa, AIO KRK 0212): Updated efficacy analyses.. Journal of Clinical Oncology. 42(16_suppl). 3506–3506. 1 indexed citations
2.
3.
Karthaus, Meinolf, Annika Kurreck, Alexej Ballhausen, et al.. (2023). Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic colorectal cancer: Subgroup analysis of patients treated within the PanaMa trial (AIO KRK 0212). International Journal of Cancer. 154(5). 863–872. 2 indexed citations
4.
Kurreck, Annika, Alexander Beck, Uli Fehrenbach, et al.. (2022). Depth of response of induction therapy and consecutive maintenance treatment in patients with RAS wild-type metastatic colorectal cancer: An analysis of the PanaMa trial (AIO KRK 0212). European Journal of Cancer. 178. 37–48. 3 indexed citations
5.
Grohé, Christian, Werner J. Blau, Wolfgang Gleiber, et al.. (2022). Real-World Efficacy of Nintedanib Plus Docetaxel After Progression on Immune Checkpoint Inhibitors: Results From the Ongoing, Non-interventional VARGADO Study. Clinical Oncology. 34(7). 459–468. 13 indexed citations
6.
Modest, Dominik Paul, Meinolf Karthaus, S. Frühauf, et al.. (2021). Maintenance therapy with 5-fluoruracil/leucovorin (5FU/LV) plus panitumumab (pmab) or 5FU/LV alone in RAS wildtype (WT) metastatic colorectal cancer (mCRC) - the PANAMA trial (AIO KRK 0212).. Journal of Clinical Oncology. 39(15_suppl). 3503–3503. 1 indexed citations
7.
8.
9.
10.
Grohé, Christian, Wolfgang Blau, Wolfgang Gleiber, et al.. (2019). Nintedanib plus docetaxel in lung adenocarcinoma patients (pts) following treatment with immune checkpoint inhibitors (ICIs): Preliminary efficacy and safety results of the non-interventional study VARGADO.. Journal of Clinical Oncology. 37(15_suppl). 9074–9074. 3 indexed citations
11.
Grohé, Christian, Wolfgang Gleiber, Siegfried Haas, et al.. (2019). Nintedanib Plus Docetaxel After Progression on Immune Checkpoint Inhibitor Therapy: Insights from VARGADO, A Prospective Study in Patients with Lung Adenocarcinoma. Future Oncology. 15(23). 2699–2706. 21 indexed citations
12.
13.
Hering, Sandra, et al.. (2015). Paternity testing of two female siblings with Investigator Argus X-12 kit: A case with several rare mutation and recombination events. Forensic science international. Genetics supplement series. 5. e341–e343. 5 indexed citations
14.
Gingrich, André & Siegfried Haas. (2014). Southwest Arabia across History. Verlag der österreichischen Akademie der Wissenschaften eBooks. 1 indexed citations
15.
Arvio, Maria, H Kääriäinen, Hilde Van Esch, et al.. (2013). Novel changes in the SLC16A2 gene identified by X-exome sequencing in two Finnish families with Allan-Herndon Dudley syndrome. European Journal of Human Genetics. 21. 161–162. 1 indexed citations
16.
Riesebrodt, Martin, et al.. (2004). Religiöser Fundamentalismus: vom Kolonialismus zur Globalisierung. 1 indexed citations
17.
Kussmaúl, K., et al.. (1991). Metallographic examination of the heat‐affected zone of a test weld in a type X 20 CrMoV 12 1 steel. Steel Research. 62(2). 83–85. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yiu-Keung Lau Breakdown of academic impact, for papers by Federica D’Incà Breakdown of academic impact, for papers by Elia Seguí Breakdown of academic impact, for papers by B. Bermejo De Las Heras Breakdown of academic impact, for papers by M.R. García-Campelo Breakdown of academic impact, for papers by Sabela Recalde Breakdown of academic impact, for papers by Daphné t’Kint de Roodenbeke Breakdown of academic impact, for papers by E. Millastre Breakdown of academic impact, for papers by Sonia Del Barco Berrón Breakdown of academic impact, for papers by Annette Kolodzie
Rankless by CCL
2026